Research
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g366 (Published 11 February 2014) Cite this as: BMJ 2014;348:g366
Related articles
- Research Published: 23 March 2006; BMJ 332 doi:10.1136/bmj.38764.572569.7C
- RESEARCH Published: 03 March 2006; BMJ doi:10.1136/bmj.38764.572569.7C
- Editor's Choice Published: 13 February 2014; BMJ 348 doi:10.1136/bmj.g1521
- News Published: 18 February 2014; BMJ 348 doi:10.1136/bmj.g1625
- Editorial Published: 17 June 2014; BMJ 348 doi:10.1136/bmj.g3824
- Research Published: 07 January 2015; BMJ 350 doi:10.1136/bmj.g7773
- Analysis Published: 04 March 2015; BMJ 350 doi:10.1136/bmj.h867
- Editorial Published: 16 September 2015; BMJ 351 doi:10.1136/bmj.h4601
- Research Published: 24 February 2021; BMJ 372 doi:10.1136/bmj.n256
See more
- Cancer: Government backs multiple blood tests as part of £11m early diagnosis pushBMJ October 09, 2024, 387 q2212; DOI: https://doi.org/10.1136/bmj.q2212
- US women must be told breast density after mammogram, says FDABMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045
- Government considers outdoor smoking ban in EnglandBMJ August 30, 2024, 386 q1908; DOI: https://doi.org/10.1136/bmj.q1908
- US spends $43bn a year on cancer screeningBMJ August 12, 2024, 386 q1787; DOI: https://doi.org/10.1136/bmj.q1787
- Johnson & Johnson pays $700m to 42 US states to settle Baby Powder asbestos claimsBMJ June 26, 2024, 385 q1425; DOI: https://doi.org/10.1136/bmj.q1425
Cited by...
- Screening for breast cancer with mammography
- Screening for breast cancer: A systematic review update to inform the Canadian Task Force on Preventive Health Care guideline
- Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study
- BREAst screening Tailored for HEr (BREATHE) - A Study Protocol On Personalised Risk-based Breast Cancer Screening Programme
- Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai
- The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment
- UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis
- Is mammography screening beneficial: An individual-based stochastic model for breast cancer incidence and mortality
- Physician Perspectives on Mammography Screening for Average-Risk Women: "Like a Double-Edged Sword"
- Importance of quality in breast cancer screening practice - a natural experiment in Alberta, Canada
- Interpretation of breast cancer screening guideline for Chinese women
- Can nudge-interventions address health service overuse and underuse? Protocol for a systematic review
- Quaternary prevention: a balanced approach to demedicalisation
- Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer
- Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position
- A systematic review of barriers and enablers to South Asian womens attendance for asymptomatic screening of breast and cervical cancers in emigrant countries
- Breast cancer screening
- Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort
- Examining screening mammography participation among women aged 40 to 74
- Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change
- Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data
- Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
- CJS debate: Is mammography useful in average-risk screening for breast cancer?
- Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi
- Womens Expectations for Breast Cancer Prevention and Early Detection: High Expectations Can Be Achieved
- Liberating the data from clinical trials
- Breast Cancer Diagnoses: The Authors Reply
- Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care
- National Expenditure For False-Positive Mammograms And Breast Cancer Overdiagnoses Estimated At $4 Billion A Year
- Mammography Rates 3 Years After the 2009 US Preventive Services Task Force Guidelines Changes
- Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality
- Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
- This American life: in the key of C(ancer)
- Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake
- Fifty years of age-based screening: time for a new risk-based screening approach
- Rethinking Breast Cancer Screening: Ultra FAST Breast Magnetic Resonance Imaging
- Cancer Care Research in North Carolina: The State of the State
- The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia?
- Controversies in Cancer Screening
- The harms and benefits of modern screening mammography
- Breast cancer screening pamphlets mislead women
- Switzerland debates dismantling its breast cancer screening programme
- Too much mammography